Mark Throsby, EVP & Chief Scientific Officer at Merus N.V. (MRUS), sold 368 shares at $10.93 ($4K) on 2020-04-02, disclosed to the SEC on 2020-04-06.
Scheduled sale ($4k) by EVP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MRUS | SELL | 2020-05-11 | $5K | — | Filing → |
| MRUS | SELL | 2020-03-10 | $7K | — | Filing → |
| MRUS | SELL | 2020-02-26 | $2.0M | — | Filing → |